References:
1. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol . 1976;116(2):180-183.
2. Han RF, Pan JG. Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology . 2006;67(6):1216-1223.
3. De Boer EC, De Jong WH, Steerenberg PA, et al. Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guerin in superficial bladder cancer. Cancer Immunol Immunother . 1992;34(5):306-312.
4. Hill AR, Premkumar S, Brustein S, et al. Disseminated tuberculosis in the acquired immunodeficiency syndrome era. Am Rev Respir Dis . 1991;144(5):1164-1170.
5. Gonzalez OY, Musher DM, Brar I, et al. Spectrum of Bacille Calmette-Guérin (BCG) Infection after Intravesical BCG Immunotherapy.Clinical Infectious Diseases . 2003;36(2):140-148.